NEW YORK, Sep 01, 2004 (United Press International via COMTEX) -- The largest U.S. drug maker, Pfizer, has terminated its Living Share discount card program for the elderly, the New York Times reported Wednesday.
In the plan's two-year-existence, the company issued about 536,000 of the cards, and company officials said all members had been notified months ago the plan was being discontinued. The seniors were also advised to sign up for various discount cards that became available under a new Medicare program that began in June.
One of the most popular drugs the plan covered was Lipitor, used for high cholesterol treatment. Under the former Pfizer card discontinued Tuesday, a 30-day supply of Lipitor cost $15 -- compared with $68 at one Internet pharmacy, or $43.32 at one Canadian Web site, the newspaper said.
So far, only about 4.1 million of the nation's 40 million Medicare beneficiaries have signed up for Medicare-approved discount cards.
Copyright 2004 by United Press International.